Vogli 0.3 Tablet MD
Marketer
Medley Pharmaceuticals
Salt Composition
Voglibose (0.3mg)
Overview Vogli 0.3 Tablet MD
DiaVogli 0.3mg tablets are prescribed for managing type 2 diabetes. This medication aids in post-meal blood glucose regulation, particularly when diet and other similar therapies prove insufficient. Administer DiaVogli 0.3mg immediately before meals; dosage frequency is determined individually by your physician to optimize glycemic control. Abrupt cessation should be avoided without medical consultation, as this can elevate blood sugar and potentially lead to severe complications such as renal impairment and vision loss. This medication forms one component of a comprehensive diabetes management plan, necessitating adherence to a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Common side effects include abdominal discomfort, gas, appetite changes, constipation, and diarrhea. Report persistent or bothersome side effects to your physician. While DiaVogli 0.3mg alone does not typically cause hypoglycemia, concomitant use with other diabetes medications (especially insulin or sulfonylureas) increases this risk. Treat hypoglycemic episodes with plain glucose; ordinary table sugar may be ineffective. Prior to commencing treatment, disclose any kidney or liver conditions. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating women should seek medical advice before use. Inform your physician about all other medications to ensure safe usage. Limit alcohol consumption, as it may heighten the risk of hypoglycemia.
Uses of Vogli 0.3 Tablet MD
Managing type 2 diabetes
Major Benefits of Vogli 0.3 Tablet MD:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Avoid contact with the tablets using damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. Vogli 0.3 Tablet MD should be consumed on an empty stomach.
Common Side effects of Vogli 0.3 Tablet MD:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vogli 0.3 Tablet MD:
Administer this medication according to your physician's prescribed dosage and schedule. Avoid contact with damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. Consume Vogli 0.3 Tablet MD on an empty stomach.
How Vogli 0.3 Tablet MD works:
Vogli 0.3 Tablet MD is an antidiabetic medication that works by blocking the action of intestinal enzymes which digest complex carbohydrates. This mechanism prevents postprandial hyperglycemia, keeping blood sugar from spiking after eating.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vogli 0.3 Tablet MD with alcohol is unsafe.
PregnancySAFE IF PRESCRIBED
The use of Vogli 0.3 Tablet MD is typically deemed safe for pregnant individuals. Preclinical trials in animals have revealed minimal or no harmful consequences for fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Vogli 0.3 Tablet MD while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vogli 0.3 mg tablets.
KidneyCAUTION
Patients with severe renal impairment should use Vogli 0.3 Tablet MD cautiously. A modified Vogli 0.3 Tablet MD dosage may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Vogli 0.3 Tablet MD. Dosage modification of Vogli 0.3 Tablet MD may be necessary. Physician consultation is advised.
What if you forget to take Vogli 0.3 Tablet MD :
Omit any missed Vogli 0.3 Tablet MD dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Vogli 0.3 Tablet MD
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |






